Ann McCormack

19PUBLICATIONS

53CO-AUTHORS

Haematological tumoursPredictive and prognostic markersAutoimmunitySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jun 18, 2026

Real-world insights in the use of temozolomide for aggressive pituitary tumours remind us what we still don't know.

|Jun 27, 2025

Assessing the clinical application of the PANOMEN 3 classification in a large cohort of pituitary tumors.

Prishila Fookeerah, Winny Varikatt, Meena Shingde

|Jun 24, 2025

Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.

Maria Fleseriu, Mark Gurnell, Ann McCormack

|Jun 12, 2025

Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas.

Gerald Raverot, Pia Burman, Ana Paula Abreu

|Mar 11, 2025

FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours.

Andreas Orsmond, Gayathri Krishnan, Lyle J Palmer

|Feb 20, 2025

Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement.

Kristina Isand, Hiroshi Arima, Jerome Bertherat

Pageof 4

Frequent Collaborators

Mark Gurnell

Nele F Lenders

Mirjam Christ-Crain

Maria Fleseriu

Gerald Raverot

Sunita M C De Sousa

Annabelle G Hayes

John Newell-Price

Joseph G Verbalis

Pia Burman

Frequent Collaborators

Mark Gurnell

Nele F Lenders

Mirjam Christ-Crain

Maria Fleseriu